关注
Shiva Najjary
Shiva Najjary
Erasmus Medical Center (Erasmus MC)
在 erasmusmc.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer
S Najjary, R Mohammadzadeh, A Mokhtarzadeh, A Mohammadi, ...
Gene 738, 144453, 2020
632020
Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells
M Shirmohamadi, E Eghbali, S Najjary, A Mokhtarzadeh, AB Kojabad, ...
Journal of cellular physiology 235 (2), 776-789, 2020
472020
siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468)
F Vahidian, E Safarzadeh, A Mohammadi, S Najjary, B Mansoori, J Majidi, ...
Molecular Biology Reports 47, 9541-9551, 2020
232020
Evaluating the role of microRNAs alterations in oral squamous cell carcinoma
M Aali, AH Mesgarzadeh, S Najjary, HM Abdolahi, AB Kojabad, ...
Gene 757, 144936, 2020
232020
miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene
S Safaei, M Amini, S Najjary, A Mokhtarzadeh, N Bolandi, H Saeedi, ...
Experimental and Molecular Pathology 125, 104753, 2022
132022
COVID-19 infection: concise review based on the immunological perspective
P Lotfinejad, Z Asadzadeh, S Najjary, MH Somi, K Hajiasgharzadeh, ...
Immunological Investigations 51 (2), 246-265, 2022
122022
Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line
S Najjary, R Mohammadzadeh, B Mansoori, F Vahidian, A Mohammadi, ...
Medical Oncology 38, 1-10, 2021
102021
Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma
Z Lotfi, S Najjary, F Lotfi, M Amini, A Baghbanzadeh, DJ Rashid, ER Asl, ...
European Journal Of Pharmacology 901, 174006, 2021
82021
Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
JWDAMM Shiva Najjary, Johan M. Kros, Willem de Koning, Disha Vadgama ...
Acta Neuropathologica Communications, 2023
32023
Association of blood cell‐based inflammatory markers with gut microbiota and cancer incidence in the Rotterdam study
S Najjary, JM Kros, BH Stricker, R Ruiter, Y Shuai, R Kraaij, K Van Steen, ...
Cancer Medicine 13 (3), e6860, 2024
12024
Non-small cell lung cancer brain metastasis: the link between molecular mechanisms and novel therapeutic approaches
S Najjary, DAM Mustafa, JM Kros
Cancer Metastasis-Molecular Mechanism and Clinical Therapy, 2022
12022
Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix
M Salarzaei, RLO van de Laar, PC Ewing-Graham, S Najjary, E van Esch, ...
International Journal of Molecular Sciences 25 (11), 6205, 2024
2024
Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers
S Najjary, W de Koning, JM Kros, DAM Mustafa
Frontiers in Immunology 14, 1305644, 2023
2023
EP094/# 1572 Unraveling the complexities of cervical cancer: exploration of molecular mechanisms and immunological dichotomies between squamous cell carcinoma and adenocarcinoma
M Salarzaei, R Van De Laar, PC Ewing-Graham, S Najjary, E Van Esch, ...
International Journal of Gynecologic Cancer 33 (Suppl 4), 2023
2023
MiR-200c Sensitizes Breast Cancer Cells to Carboplatin Treatment by Decreasing MDR1 Expression
S Najjary, S Safaee, A Mokhtarzadeh, M Amini, N Bolandi, N Alizadeh, ...
2021
The role of microRNA-34a in BACH1، PTEN and SIRT1 expression in T-cell acute lymphoblastic leukemia cell line (Jurkat)
S Najjary, R Mohammadzadeh, B Baradaran
Cellular and Molecular Research (Iranian Journal of Biology) 33 (2), 240-248, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–16